Skip to main content

SNYDER CAPITAL MANAGEMENT L P

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1050477 San Francisco, CA

Position in HALO

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$150,140,466
-$11,324,886 QoQ
Shares Held
2,323,077
-3.2% QoQ
Ownership
1.96%
of shares outstanding
% of Portfolio
2.93%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 96.09647032793146.ToString("F0")% None 3.9035296720685535.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SNYDER CAPITAL MANAGEMENT L P holds $248,509,359 across 2 Biotechnology names. HALO ranks #1 (60.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
This page
2,323,077 $150,140,466

All Filings in HALO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $150,140,466 2,323,077
2025-12-31 $161,465,352 2,399,188
2025-09-30 $200,500,118 2,733,844
2025-06-30 $176,748,197 3,397,697
2025-03-31 $234,457,210 3,674,302
2024-12-31 $199,293,737 4,168,453
2024-09-30 $232,587,127 4,063,367
2024-06-30 $211,529,792 4,039,912
2024-03-31 $167,488,794 4,117,227
2023-12-31 $137,106,779 3,709,599
2023-09-30 $165,185,662 4,324,232
2023-06-30 $155,949,077 4,323,512
2023-03-31 $164,033,076 4,295,184
2022-12-31 $226,679,016 3,983,814
2022-09-30 $174,724,413 4,418,928
2022-06-30 $180,847,656 4,110,174
2022-03-31 $161,231,091 4,042,906
2021-12-31 $163,444,763 4,064,779
2021-09-30 $139,429,723 3,427,476
2021-06-30 $144,240,505 3,176,404
2021-03-31 $121,770,653 2,920,860
2020-12-31 $140,943,042 3,300,001
2020-09-30 $88,824,481 3,379,927
2020-06-30 $91,193,410 3,401,470
2020-03-31 $61,041,095 3,393,057